JT
IOVA icon

Jupiter Topco’s Iovance Biotherapeutics IOVA Stock Holding History

Jupiter Topco’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$589K Buy
+141,672
New +$538K ﹤0.01% 2023

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jupiter Topco's IOVA Position: Q2 2026 in Review

Jupiter Topco opened a new position in Iovance Biotherapeutics (IOVA) in Q2 2026: 141,672 shares worth $589K. The stake represents ﹤0.01% of the portfolio and ranks #2023 among its holdings.

271 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Jupiter Topco held 141,672 shares of Iovance Biotherapeutics worth $589K as of Q2 2026.
  • Iovance Biotherapeutics was a new Jupiter Topco position in Q2 2026.
  • Iovance Biotherapeutics made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #2023 holding.
  • 271 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.